| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 02/27/2003 | US20030039685 Bitterness-reduced intrabuccally quick disintegrating tablets and method for reducing bitterness |
| 02/27/2003 | US20030039684 Preparation of a directly mouldable tabletting auxiliary |
| 02/27/2003 | US20030039682 Hydrophilic cotton fibers; delay absorption of aqueous solution |
| 02/27/2003 | US20030039680 Buccal, polar and non-polar spray or capsule |
| 02/27/2003 | US20030039679 Drug delivery system |
| 02/27/2003 | US20030039675 Therapeutic inhibitor of vascular smooth muscle cells |
| 02/27/2003 | US20030039669 Use of a composition containing an effective quantity of at least one chelating agent for partially or totally reducing the symptoms associated with histamine release in the organism |
| 02/27/2003 | US20030039665 Inducing immunology response; administering by nose |
| 02/27/2003 | US20030039619 Cosmetic or dermatological formulations |
| 02/27/2003 | US20030039615 Method for treating bronchial constriction and bronchospasm |
| 02/27/2003 | US20030039614 Expanding the homogeneous solution by exposing it to a change in pressure under conditions such that the solution or homogeneous dispersion does not boil |
| 02/27/2003 | US20030039613 Novel therapeutic delivery systems |
| 02/27/2003 | US20030038183 Spray gun for enteric coating and process for producing enteric coating preparation |
| 02/27/2003 | US20030037673 Method and system for treating air with an iodinated resin |
| 02/27/2003 | DE20219666U1 Dermatological covering material, e.g. face mask, for delivering cosmetic or therapeutic active agents, comprises a polymeric carrier material, preferably alginic acid |
| 02/27/2003 | DE20219665U1 Composition for treatment of obesity in animals, comprising insoluble material swellable in gastrointestinal fluid, and an animal attractant |
| 02/27/2003 | DE20219657U1 Composition for treatment of obesity, comprising ginseng component and insoluble material swellable in gastrointestinal fluid |
| 02/27/2003 | CA2493349A1 Delayed and sustained drug release |
| 02/27/2003 | CA2460352A1 Composition and transdermal drug delivery device |
| 02/27/2003 | CA2459692A1 Mucoadhesive erodible drug delivery device for controlled administration of pharmaceuticals and other active compounds |
| 02/27/2003 | CA2457330A1 Oral immunoglobulin treatment for inflammatory bowel disease |
| 02/27/2003 | CA2457163A1 Derp1 and proderp1 allergen derivatives |
| 02/27/2003 | CA2457148A1 Treatment of cancers by inhalation of stable platinum-containing formulations |
| 02/27/2003 | CA2457086A1 Oral care substance delivery strip |
| 02/27/2003 | CA2457030A1 Devices including protein matrix materials and methods of making and using same |
| 02/27/2003 | CA2456988A1 Gas microsphere liposome composites |
| 02/27/2003 | CA2456976A1 Expandable gastric retention device |
| 02/27/2003 | CA2456966A1 Lipidated glycosaminoglycan particles and their use in drug and gene delivery for diagnosis and therapy |
| 02/27/2003 | CA2456820A1 Physiological method of improving vision |
| 02/27/2003 | CA2456746A1 Method for treating lung cancers |
| 02/27/2003 | CA2456201A1 Immunomodulatory oligonucleotide formulations and methods for use thereof |
| 02/27/2003 | CA2455822A1 Matrix controlled transdermal therapeutic system for the use of pramipexole and ropinirole |
| 02/27/2003 | CA2455120A1 Method and intra sclera implant for treatment of glaucoma and presbyopia |
| 02/27/2003 | CA2454671A1 Pharmaceutical composition for nasal delivery of estradiol and norethisterone |
| 02/26/2003 | EP1285670A2 Medical adhesive composition and adhesive tape or sheet using the composition |
| 02/26/2003 | EP1285668A1 Preparations for evaluating eliminative ability of stomach |
| 02/26/2003 | EP1285665A1 Liquid gonadotropin containing formulations |
| 02/26/2003 | EP1285655A1 Stabilized pharmaceutical compositions containing calcium channel blockers |
| 02/26/2003 | EP1285649A1 Bilayered dispersible tablet formulation comprising amoxycillin and clavulanate in separate layers |
| 02/26/2003 | EP1285021A1 Material based on biodegradable polymers and method for preparing same |
| 02/26/2003 | EP1284992A2 Polyubiquitin based hydrogel and uses thereof |
| 02/26/2003 | EP1284958A1 Method of inhibiting amyloid protein aggregation and imaging amyloid deposits using aminoidane derivatives |
| 02/26/2003 | EP1284771A1 Aerosol container for formulations of salmeterol xinafoate |
| 02/26/2003 | EP1284754A1 Gel-like pharmaceutical composition for subcutaneous administration comprising bisphosphonic acids or their salts |
| 02/26/2003 | EP1284750A1 Pharmaceutical composition |
| 02/26/2003 | EP1284744A1 Antimigraine combination comprising sapindus and emblica extracts |
| 02/26/2003 | EP1284738A1 (+) naloxone and epinephrine combination therapy |
| 02/26/2003 | EP1284736A2 Opioid antagonist compositions and dosage forms |
| 02/26/2003 | EP1284727A1 Intracorporeal medicaments for photodynamic treatment of disease |
| 02/26/2003 | EP1284723A1 Compositions and therapies for hyperlipidaemia-associated disorders |
| 02/26/2003 | EP1284722A2 Compositions containing a benzamide disulfide derivative for treating allergic diseases |
| 02/26/2003 | EP1284719A2 The use of a calcium channel blocker for treating renal disorders |
| 02/26/2003 | EP1284718A2 Occlusive transdermal therapeutic system wit a non-occlusive backing layer |
| 02/26/2003 | EP1284717A1 Formulation based on heparin, glycosaminoglycan or heparinoid, use of the formulation and the formulation base |
| 02/26/2003 | EP1284716A2 Self-emulsifying active substance formulation and use of this formulation |
| 02/26/2003 | EP1284711A1 Blister package for topiramate tablets |
| 02/26/2003 | EP1284601A2 Allantoin-containing skin cream |
| 02/26/2003 | EP1169019B1 Pharmaceutical aerosol formulation |
| 02/26/2003 | EP1153615B1 Pharmaceutical formulation for intravenous or intramuscular octreotide administration |
| 02/26/2003 | EP1028746B1 Method for producing igf-i sustained-release formulations |
| 02/26/2003 | EP0969827B1 Mixture of primary fatty acids obtained from sugar cane wax |
| 02/26/2003 | EP0969803B1 Emulsifier-free finely dispersed systems of the water-in-oil type |
| 02/26/2003 | EP0946169B1 Method of producing a sustained-release preparation |
| 02/26/2003 | EP0862417B1 Pharmaceutical composition for topical application |
| 02/26/2003 | EP0850059B1 Pharmaceutical formulations containing darifenacin |
| 02/26/2003 | EP0799055B1 Selective and non-invasive visualization or treatment of vasculature |
| 02/26/2003 | EP0732913B1 SYNTHETIC VISCOELASTIC MATERIAL for physiological applications such as FOR OPHTHALMIC APPLICATIONs |
| 02/26/2003 | EP0729748B1 Process for producing stable medicinal composition |
| 02/26/2003 | EP0655914B1 Use of Histamine-2 agonists for treatment of sexual dysfunction |
| 02/26/2003 | CN2537411Y Medicinal cushion convenient for storing and carrying |
| 02/26/2003 | CN1399655A Swelling and deswelling polymer blends |
| 02/26/2003 | CN1399589A Process for preparing foam component |
| 02/26/2003 | CN1399565A Propellant free spray-on skin patch composition for improving wound healing and for drug administration |
| 02/26/2003 | CN1399561A Conjugate having cleavable linkage for use in liposome |
| 02/26/2003 | CN1399560A Novel albumin-free factor VIII formulations |
| 02/26/2003 | CN1399551A Pernasal preparation |
| 02/26/2003 | CN1399549A Ultrafinel-carnitine, methods of preparing the same, compositions containing the same, and methods of using the same |
| 02/26/2003 | CN1399548A Composition for treatment of external secretion disorders |
| 02/26/2003 | CN1399544A Multilayer preparation for controlled, pulsed release of active substances |
| 02/26/2003 | CN1399543A Controlled release composition comprising nimesulide |
| 02/26/2003 | CN1399542A Pharmaceutical carrier formulation |
| 02/26/2003 | CN1399541A Colloidal suspension of submicronic particles as vectors for active principles and method for preparing same |
| 02/26/2003 | CN1399540A Aerosol composition comprising formoterol |
| 02/26/2003 | CN1399539A Adjuvant comprising polyxyethylene alkyl ether or ester and at least one nonionic surfactant |
| 02/26/2003 | CN1399533A Improved transdermal contraceptive delivery system and process |
| 02/26/2003 | CN1399517A Release of lipophilic active agents from chewing gum |
| 02/26/2003 | CN1398873A Dinucleotide for treating pulmonary tuberulosis |
| 02/26/2003 | CN1398637A Thymosin alpha-1 microball prepn and its prepn process |
| 02/26/2003 | CN1398636A Thymosin composition injection and its prepn |
| 02/26/2003 | CN1398618A Chinese medicine capsule for treating rbeumatism and protrusion of lumber interverterbral disc |
| 02/26/2003 | CN1398603A Plaster for treating pain in neck, shoulder, waist and leg and its prepn process |
| 02/26/2003 | CN1398599A Rheumatism treating nux vomica medicine powder |
| 02/26/2003 | CN1398590A Recipe and prepn of progesterone capsule |
| 02/26/2003 | CN1398587A Slow-releasing Metronidazole prepn for position of colon |
| 02/26/2003 | CN1398585A Slow-releasing bFGF-PLA-PEG microball and its prepn and use |
| 02/26/2003 | CN1398584A Slow-releasing bFGF-PLGA microball and its prepn and use |
| 02/26/2003 | CN1398583A Superfine medicated tea and its prepn and use |
| 02/26/2003 | CN1398582A Local acne treating device |
| 02/26/2003 | CN1102065C Linolenic acid soft capsule and production process thereof |
| 02/26/2003 | CN1102049C Tonic compound deer fetus ointment and its preparation method |